{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T02:52:56Z","timestamp":1782355976877,"version":"3.54.5"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T00:00:00Z","timestamp":1691366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T00:00:00Z","timestamp":1691366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mycopathologia"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s11046-023-00756-8","type":"journal-article","created":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T18:02:30Z","timestamp":1691431350000},"page":"705-711","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Role of C-Reactive Protein and Erythrocyte Sedimentation Rate in the Diagnosis and Monitoring of Treatment Response in Treatment Na\u00efve Subjects with Chronic Pulmonary Aspergillosis"],"prefix":"10.1007","volume":"188","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6505-6019","authenticated-orcid":false,"given":"Inderpaul Singh","family":"Sehgal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahajal","family":"Dhooria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivaprakash M.","family":"Rudramurthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuruswamy Thurai","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valliappan","family":"Muthu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashutosh Nath","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandeep","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pulkit","family":"Rastogi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritesh","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,7]]},"reference":[{"issue":"7","key":"756_CR1","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1080\/17476348.2020.1750956","volume":"14","author":"IS Sehgal","year":"2020","unstructured":"Sehgal IS, Dhooria S, Muthu V, Prasad KT, Agarwal R. An overview of the available treatments for chronic cavitary pulmonary aspergillosis. Expert Rev Respir Med. 2020;14(7):715\u201327. https:\/\/doi.org\/10.1080\/17476348.2020.1750956.","journal-title":"Expert Rev Respir Med"},{"issue":"Suppl 3","key":"756_CR2","doi-asserted-by":"publisher","first-page":"S265","DOI":"10.1086\/376526","volume":"37","author":"DW Denning","year":"2003","unstructured":"Denning DW, Riniotis K, Dobrashian R, Sambatakou H. Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review. Clin Infect Dis. 2003;37(Suppl 3):S265\u201380. https:\/\/doi.org\/10.1086\/376526.","journal-title":"Clin Infect Dis"},{"issue":"47","key":"756_CR3","doi-asserted-by":"publisher","first-page":"48487","DOI":"10.1074\/jbc.R400025200","volume":"279","author":"S Black","year":"2004","unstructured":"Black S, Kushner I, Samols D. C-reactive protein. J Biol Chem. 2004;279(47):48487\u201390. https:\/\/doi.org\/10.1074\/jbc.R400025200.","journal-title":"J Biol Chem"},{"issue":"8","key":"756_CR4","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1001\/archinte.1986.00360200151024","volume":"146","author":"RM Fincher","year":"1986","unstructured":"Fincher RM, Page MI. Clinical significance of extreme elevation of the erythrocyte sedimentation rate. Arch Intern Med. 1986;146(8):1581\u20133.","journal-title":"Arch Intern Med"},{"issue":"6","key":"756_CR5","first-page":"317","volume":"115","author":"C Bray","year":"2016","unstructured":"Bray C, Bell LN, Liang H, Haykal R, Kaiksow F, Mazza JJ, et al. Erythrocyte sedimentation rate and C-reactive protein measurements and their relevance in clinical medicine. WMJ. 2016;115(6):317\u201321.","journal-title":"WMJ"},{"issue":"12","key":"756_CR6","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1172\/jci18921","volume":"111","author":"MB Pepys","year":"2003","unstructured":"Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003;111(12):1805\u201312. https:\/\/doi.org\/10.1172\/jci18921.","journal-title":"J Clin Invest"},{"issue":"5","key":"756_CR7","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/myc.12152","volume":"57","author":"KE Schweer","year":"2014","unstructured":"Schweer KE, Bangard C, Hekmat K, Cornely OA. Chronic pulmonary aspergillosis. Mycoses. 2014;57(5):257\u201370. https:\/\/doi.org\/10.1111\/myc.12152.","journal-title":"Mycoses"},{"issue":"2","key":"756_CR8","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1159\/000362674","volume":"88","author":"C Godet","year":"2014","unstructured":"Godet C, Philippe B, Laurent F, Cadranel J. Chronic pulmonary aspergillosis: an update on diagnosis and treatment. Respiration. 2014;88(2):162\u201374. https:\/\/doi.org\/10.1159\/000362674.","journal-title":"Respiration"},{"issue":"4","key":"756_CR9","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/s12281-017-0304-7","volume":"11","author":"F Maghrabi","year":"2017","unstructured":"Maghrabi F, Denning DW. The management of chronic pulmonary aspergillosis: The UK national aspergillosis centre approach. Curr Fungal Infect Rep. 2017;11(4):242\u201351. https:\/\/doi.org\/10.1007\/s12281-017-0304-7.","journal-title":"Curr Fungal Infect Rep"},{"issue":"9","key":"756_CR10","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.cmi.2019.01.007","volume":"25","author":"IS Sehgal","year":"2019","unstructured":"Sehgal IS, Dhooria S, Choudhary H, Aggarwal AN, Garg M, Chakrabarti A, et al. Monitoring treatment response in chronic pulmonary aspergillosis: role of clinical, spirometric and immunological markers. Clin Microbiol Infect. 2019;25(9):1157. https:\/\/doi.org\/10.1016\/j.cmi.2019.01.007.","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"756_CR11","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1111\/myc.12987","volume":"62","author":"IS Sehgal","year":"2019","unstructured":"Sehgal IS, Dhooria S, Choudhary H, Aggarwal AN, Garg M, Chakrabarti A, et al. Efficiency of a fumigatus-specific IgG and galactomannan testing in the diagnosis of simple aspergilloma. Mycoses. 2019;62(12):1108\u201315. https:\/\/doi.org\/10.1111\/myc.12987.","journal-title":"Mycoses"},{"key":"756_CR12","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01821-18","author":"IS Sehgal","year":"2019","unstructured":"Sehgal IS, Dhooria S, Choudhary H, Aggarwal AN, Garg M, Chakrabarti A, et al. Utility of serum and bronchoalveolar lavage fluid galactomannan in diagnosis of chronic pulmonary aspergillosis. J Clin Microbiol. 2019. https:\/\/doi.org\/10.1128\/JCM.01821-18.","journal-title":"J Clin Microbiol"},{"issue":"3","key":"756_CR13","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.jaip.2018.08.034","volume":"7","author":"IS Sehgal","year":"2019","unstructured":"Sehgal IS, Choudhary H, Dhooria S, Aggarwal AN, Garg M, Chakrabarti A, et al. Is There an overlap in immune response between allergic bronchopulmonary and chronic pulmonary aspergillosis? J Allergy Clin Immunol Pract. 2019;7(3):969\u201374. https:\/\/doi.org\/10.1016\/j.jaip.2018.08.034.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"10","key":"756_CR14","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1111\/myc.12815","volume":"61","author":"IS Sehgal","year":"2018","unstructured":"Sehgal IS, Choudhary H, Dhooria S, Aggarwal AN, Garg M, Chakrabarti A, et al. Diagnostic cut-off of Aspergillus fumigatus-specific IgG in the diagnosis of chronic pulmonary aspergillosis. Mycoses. 2018;61(10):770\u20136. https:\/\/doi.org\/10.1111\/myc.12815.","journal-title":"Mycoses"},{"issue":"7","key":"756_CR15","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/s1473-3099(22)00057-3","volume":"22","author":"IS Sehgal","year":"2022","unstructured":"Sehgal IS, Dhooria S, Muthu V, Prasad KT, Aggarwal AN, Chakrabarti A, et al. Efficacy of 12-months oral itraconazole versus 6-months oral itraconazole to prevent relapses of chronic pulmonary aspergillosis: an open-label, randomised controlled trial in India. Lancet Infect Dis. 2022;22(7):1052\u201361. https:\/\/doi.org\/10.1016\/s1473-3099(22)00057-3.","journal-title":"Lancet Infect Dis"},{"issue":"6361","key":"756_CR16","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1136\/bmj.286.6361.266","volume":"286","author":"A Miller","year":"1983","unstructured":"Miller A, Green M, Robinson D. Simple rule for calculating normal erythrocyte sedimentation rate. Br Med J (Clin Res Ed). 1983;286(6361):266. https:\/\/doi.org\/10.1136\/bmj.286.6361.266.","journal-title":"Br Med J (Clin Res Ed)"},{"issue":"4","key":"756_CR17","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1002\/acr.20052","volume":"62","author":"I Kushner","year":"2010","unstructured":"Kushner I, Samols D, Magrey M. A unifying biologic explanation for \u201chigh-sensitivity\u201d C-reactive protein and \u201clow-grade\u201d inflammation. Arthritis Care Res (Hoboken). 2010;62(4):442\u20136. https:\/\/doi.org\/10.1002\/acr.20052.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"8","key":"756_CR18","doi-asserted-by":"publisher","first-page":"811","DOI":"10.3109\/13693786.2013.806826","volume":"51","author":"BW Jhun","year":"2013","unstructured":"Jhun BW, Jeon K, Eom JS, Lee JH, Suh GY, Kwon OJ, et al. Clinical characteristics and treatment outcomes of chronic pulmonary aspergillosis. Med Mycol. 2013;51(8):811\u20137. https:\/\/doi.org\/10.3109\/13693786.2013.806826.","journal-title":"Med Mycol"},{"issue":"12","key":"756_CR19","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1086\/657306","volume":"51","author":"TW Felton","year":"2010","unstructured":"Felton TW, Baxter C, Moore CB, Roberts SA, Hope WW, Denning DW. Efficacy and safety of posaconazole for chronic pulmonary aspergillosis. Clin Infect Dis. 2010;51(12):1383\u201391. https:\/\/doi.org\/10.1086\/657306.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"756_CR20","doi-asserted-by":"publisher","first-page":"e479","DOI":"10.1016\/j.ijid.2009.07.011","volume":"14","author":"HS Nam","year":"2010","unstructured":"Nam HS, Jeon K, Um SW, Suh GY, Chung MP, Kim H, et al. Clinical characteristics and treatment outcomes of chronic necrotizing pulmonary aspergillosis: a review of 43 cases. Int J Infect Dis. 2010;14(6):e479\u201382. https:\/\/doi.org\/10.1016\/j.ijid.2009.07.011.","journal-title":"Int J Infect Dis"},{"issue":"5","key":"756_CR21","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1016\/j.jinf.2005.08.022","volume":"52","author":"LR Jain","year":"2006","unstructured":"Jain LR, Denning DW. The efficacy and tolerability of voriconazole in the treatment of chronic cavitary pulmonary aspergillosis. J Infect. 2006;52(5):e133\u20137. https:\/\/doi.org\/10.1016\/j.jinf.2005.08.022.","journal-title":"J Infect"},{"key":"756_CR22","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s13000-015-0388-8","volume":"10","author":"N Tochigi","year":"2015","unstructured":"Tochigi N, Ishiwatari T, Okubo Y, Ando T, Shinozaki M, Aki K, et al. Histological study of chronic pulmonary aspergillosis. Diagn Pathol. 2015;10:153. https:\/\/doi.org\/10.1186\/s13000-015-0388-8.","journal-title":"Diagn Pathol"},{"key":"756_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/jof7100842","author":"SF Huang","year":"2021","unstructured":"Huang SF, Huang CC, Chou KT, Chan YJ, Yang YY, Wang FD. Chronic pulmonary aspergillosis: disease severity using image analysis and correlation with systemic proinflammation and predictors of clinical outcome. J Fungi (Basel). 2021. https:\/\/doi.org\/10.3390\/jof7100842.","journal-title":"J Fungi (Basel)"},{"key":"756_CR24","doi-asserted-by":"publisher","DOI":"10.1111\/crj.13171","author":"W Osborne","year":"2020","unstructured":"Osborne W, Fernandes M, Brooks S, Grist E, Sayer C, Hansell DM, et al. Pulsed echinocandin therapy in azole intolerant or multiresistant chronic pulmonary aspergillosis: a retrospective review at a UK tertiary centre. Clin Respir J. 2020. https:\/\/doi.org\/10.1111\/crj.13171.","journal-title":"Clin Respir J"},{"issue":"4","key":"756_CR25","first-page":"167","volume":"61","author":"S Kohno","year":"2018","unstructured":"Kohno S, Izumikawa K, Ogawa K, Kurashima A, Okimoto N, Suzuki K, et al. Intravenous liposomal amphotericin B versus voriconazole for chronic pulmonary aspergillosis: a multicenter trial in Japan. Acta Med Nagasaki. 2018;61(4):167\u201376.","journal-title":"Acta Med Nagasaki"}],"container-title":["Mycopathologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-023-00756-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11046-023-00756-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11046-023-00756-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T12:15:06Z","timestamp":1696940106000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11046-023-00756-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,7]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["756"],"URL":"https:\/\/doi.org\/10.1007\/s11046-023-00756-8","relation":{},"ISSN":["0301-486X","1573-0832"],"issn-type":[{"value":"0301-486X","type":"print"},{"value":"1573-0832","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,7]]},"assertion":[{"value":"20 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"ISS, SD, KTP, MG, SMR, VM, ANA, and RA: conflicts of interest-none; financial disclosures- none.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}